ArticleChemPlusChem2016
Macrocycle-Based Hydroxamate Ligands for Complexation and Immunoconjugation of
Open access · greenAbstract read
In one paragraph
Article in ChemPlusChem, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 60 citations in OpenAlex.
- Synthesis and Evaluation of D8W, an Octadentate Desferrioxamine Analogue with Enhanced Water Solubility Designed forMolecular pharmaceutics · 2026Article
- Fluorescent Deferoxamine Complexes of Cu(II) and Zr(IV): Insights in the Development of Dual Imaging Probes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Article
- Novel Chelating Agents for Zirconium-89-Positron Emission Tomography (PET) Imaging: Synthesis, DFT Calculation, Radiolabeling, andACS omega · 2022Article
- Entropy and Enthalpy Effects on Metal Complex Formation in Non-Aqueous Solvents: The Case of Silver(I) and Monoamines.Entropy (Basel, Switzerland) · 2022Article
- A Semi Rigid Novel Hydroxamate AMPED-Based Ligand forMolecules (Basel, Switzerland) · 2021Article
- Thermodynamic Stability and Speciation of Ga(III) and Zr(IV) Complexes with High-Denticity Hydroxamate Chelators.Inorganic chemistry · 2021Article
- The Race for Hydroxamate-Based Zirconium-89 Chelators.Cancers · 2021Review
- HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging.European journal of nuclear medicine and molecular imaging · 2021Review
- Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinicalEuropean journal of nuclear medicine and molecular imaging · 2021Article
- Polyazamacrocycle Ligands FacilitateInorganic chemistry · 2020Article
- A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89.Inorganic chemistry · 2020Article
- Article
- ImmunoPET: Concept, Design, and Applications.Chemical reviews · 2020Review
- Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* forEuropean journal of nuclear medicine and molecular imaging · 2019Article
- Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO.Organic & biomolecular chemistry · 2019Article
- Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89.Biomolecules · 2019Article
- A comprehensively revised strategy that improves the specific activity and long-term stability of clinically relevantDalton transactions (Cambridge, England : 2003) · 2018Article
- Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers.Journal of labelled compounds & radiopharmaceuticals · 2018Review
- Recent Advances in Zirconium-89 Chelator Development.Molecules (Basel, Switzerland) · 2018Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Eszter BorosThe Athinoula A. Martinos Center for Biomedical Imaging Department of Radiology, Massachusetts General Hospital Harvard Medical School, 149 Thirteenth Street, Suite 2301 Charlestown, MA 02129 (USA).
Jason P HollandDivision of Nuclear Medicine and Molecular Imaging Massachusetts General Hospital, Department of Radiology Harvard Medical School, 55 Fruit Street, White 427 Boston, MA 02114 (USA).
Nathaniel KentonThe Athinoula A. Martinos Center for Biomedical Imaging Department of Radiology, Massachusetts General Hospital Harvard Medical School, 149 Thirteenth Street, Suite 2301 Charlestown, MA 02129 (USA).
Nicholas RotileThe Athinoula A. Martinos Center for Biomedical Imaging Department of Radiology, Massachusetts General Hospital Harvard Medical School, 149 Thirteenth Street, Suite 2301 Charlestown, MA 02129 (USA).
Peter CaravanThe Athinoula A. Martinos Center for Biomedical Imaging Department of Radiology, Massachusetts General Hospital Harvard Medical School, 149 Thirteenth Street, Suite 2301 Charlestown, MA 02129 (USA).
Harvard University · USMassachusetts General Hospital · USAthinoula A. Martinos Center for Biomedical Imaging · US
Funding
Stable, High Relaxivity MRI Contrast AgentsR01EB009062 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2009 to 2017
$4.9MInveon: A Triple Modality Biomedical Imaging SystemS10RR029495 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BROWNELL, ANNA-LIISA · 2010 to 2010
$1.3MDevelopment of Zr-89 based immunoPET agents for idiopathic pulmonary fibrosisR00HL125728 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI BOROS, ESZTER · 2018 to 2020
$744k500 MHz NMR Spectrometer for Molecular Imaging ApplicationsS10RR023385 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2007 to 2007
$500kUpgrade for Biospec Console and accessories for the 9.4T/20cm MagnetS10RR025563 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI DAI, GUANGPING · 2009 to 2009
$498kHPLC-ICP-MS SystemS10OD010650 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI CARAVAN, PETER D · 2013 to 2013
$371kIVIS Spectrum Imaging SystemS10RR025504 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI MOORE, ANNA · 2009 to 2009
$341kDevelopment of Zr-89 based ImmunoPET agents for Idiopathic Pulmonary FibrosisK99HL125728 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BOROS, ESZTER · 2015 to 2016
$311kNCRR NIH HHS S10 RR023385NCRR NIH HHS S10 RR025563NCRR NIH HHS S10 RR029495NHLBI NIH HHS K99 HL125728NHLBI NIH HHS R00 HL125728NIBIB NIH HHS R01 EB009062NIH HHS S10 OD010650
Abstract
Four novel chelators (
Indexed as
antitumor agentsimaging agentsmacrocyclesradiopharmaceuticalszirconium
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.